Abstract: A method of producing a non-erythroid protein in erythrocytes of a transgenic animal using an erythroid-specific promoter includes synthesizing an erythroid-specific globin gene promoter and globin gene locus control region and cloning the promoter and the globin gene locus control region and a gene encoding a non-erythroid protein into a vector to obtain a transgene; introducing the transgene in pronuclear embryos collected from a mammalian animal in vitro; transplanting the pronuclear embryos containing the transgene into oviduct of a female recipient of the mammalian animal to obtain a transgenic animal which then expresses the non-erythroid protein in progenitor cells of erythrocytes; and collecting blood from the transgenic animal and isolating the non-erythroid protein from the erythrocytes.

Abstract: A two-dimensional code, a two-dimensional code generation method, identification method, generation apparatus, and identification apparatus, and a storage medium are provided. The two-dimensional code includes a square module array including an array of m*m modules, a location detection pattern and a data information pattern. The location detection pattern determines a location of the two-dimensional code, the data information pattern is configured to carry data information, each module of the array of m*m modules is at least one of a first-type module and a second-type module, a color attribute of the first-type module is different from a color attribute of the second-type module, and m is at least one of 17, 18, 19, and 20.

Abstract: Embodiments of this application disclose an object on which a two-dimensional code is disposed, a two-dimensional code generation method, identification method, generation apparatus, and identification apparatus, and a storage medium. The two-dimensional code includes a square module array of m*m modules. The square module array includes a location detection pattern and a data information pattern. The location detection pattern is used for determining a location of the two-dimensional code. The data information pattern is used for carrying data. m=17 or 18 or 19 or 20. Even if printed in a miniature area whose side length is 0.5 cm to 0.7 cm, a miniature two-dimensional code provided in the embodiments of this application can still be normally identified, and is suitable for being used in a small area application scenario such as an inner side of a bottle cap or a corner of an object.

Abstract: A method for detecting a two-dimensional barcode is provided. Binarization processing is performed on an image to obtain a binary image. Whether the binary image has a target pattern is determined, and it is determined that the binary image has a two-dimensional barcode in response to determining that the binary image has the target pattern. An enlarged image of the two-dimensional barcode is obtained, and two-dimensional barcode detection is performed on the enlarged image of the two-dimensional barcode.

Abstract: The disclosure includes a method of inducing direct reprogramming (transdifferentiation) into non-oncogenic cells accompanied by tumor cell apoptosis in human tumor cells using a small molecule composition, based on the mechanism of chemical-induction of direct cellular reprogramming. The disclosure also includes a small molecule composition used for the method, and culture media and agents prepared from the composition.

Abstract: A method for detecting a two-dimensional barcode is provided. Binarization processing is performed on an image to obtain a binary image. Whether the binary image has a target pattern is determined, and it is determined that the binary image has a two-dimensional barcode in response to determining that the binary image has the target pattern. An enlarged image of the two-dimensional barcode is obtained, and two-dimensional barcode detection is performed on the enlarged image of the two-dimensional barcode.

Abstract: The disclosure includes a method of inducing direct reprogramming (transdifferentiation) into non-oncogenic cells accompanied by tumor cell apoptosis in human tumor cells using a small molecule composition, based on the mechanism of chemical-induction of direct cellular reprogramming. The disclosure also includes a small molecule composition used for the method, and culture media and agents prepared from the composition.

Abstract: A method of operating an RFID system and an RFID system in a power-saving mode are disclosed. In one embodiment, the system comprises at least one reader and at least one tag. The at least one reader may transmit a wake-up signal to the at least one tag when turning on, and the at least one tag stays alternatively in a sniff mode and a sleep mode at an alternative period before receiving the wake-up signal. The method may comprise modulating the wake-up signal by using N time markers.

Abstract: Nucleic acid molecules encoding full length PTP20, PCP-2, BDP1, mCLK2, mCLK3, mCLK4, and SIRP polypeptides, portions of such nucleic acid molecules, nucleic acid vectors containing such nucleic acid molecules, recombinant cells containing such nucleic acid vectors, polypeptides purified from such recombinant cells, antibodies to such polypeptides, and methods of identifying compounds that bind such polypeptides or abrogate their interactions with natural binding partners. Methods for diagnosing abnormal conditions in an organism with PTP20, PCP-2, BDP1, mCLK2, mCLK3, mCLK4, and SIRP related molecules or compounds. PTP20, PCP-2, BDP1, mCLK2, mCLK3, mCLK4, or SIRP polypeptides, nucleic acids encoding such polypeptides, cells, tissues and animals containing such nucleic acids, antibodies to such polypeptides, assays utilizing such polypeptides, and methods relating to all of the foregoing.

Abstract: Nucleic acid molecules encoding full length PTP20, PCP-2, BDP1, mCLK2, mCLK3, mCLK4, and SIRP polypeptides, portions of such nucleic acid molecules, nucleic acid vectors containing such nucleic acid molecules, recombinant cells containing such nucleic acid vectors, polypeptides purified from such recombinant cells, antibodies to such polypeptides, and methods of identifying compounds that bind such polypeptides or abrogate their interactions with natural binding partners. Methods for diagnosing abnormal conditions in an organism with PTP20, PCP-2, BDP1, mCLK2, mCLK3, mCLK4, and SIRP related molecules or compounds. PTP20, PCP-2, BDP1, mCLK2, mCLK3, mCLK4, or SIRP polypeptides, nucleic acids encoding such polypeptides, cells, tissues and animals containing such nucleic acids, antibodies to such polypeptides, assays utilizing such polypeptides, and methods relating to all of the foregoing.

Abstract: A method of using a 3D polygonization operation to make a 2D picture show facial expression including the step of setting control points of a 2D picture as Z=0 or Z≡0 to form a meshed plain model, and the step of attaching the plain model thus obtained to the 2D picture.

Abstract: Nucleic acid molecules encoding full length PTP20, PCP-2, BDP1, mCLK2, mCLK3, mCLK4, and SIRP polypeptides, portions of such nucleic acid molecules, nucleic acid vectors containing such nucleic acid molecules, recombinant cells containing such nucleic acid vectors, polypeptides purified from such recombinant cells, antibodies to such polypeptides, and methods of identifying compounds that bind such polypeptides or abrogate their interactions with natural binding partners. Methods for diagnosing abnormal conditions in an organism with PTP20, PCP-2, BDP1, mCLK2, mCLK3, mCLK4, and SIRP related molecules or compounds. PTP20, PCP-2, BDP1, mCLK2, mCLK3, mCLK4, or SIRP polypeptides, nucleic acids encoding such polypeptides, cells, tissues and animals containing such nucleic acids, antibodies to such polypeptides, assays utilizing such polypeptides, and methods relating to all of the foregoing.

Abstract: A method of using a 3D polygonization operation to make a 2D picture show facial expression including the step of setting control points of a 2D picture as Z=0 or Z≡0 to form a meshed plain model, and the step of attaching the plain model thus obtained to the 2D picture.